Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 40 mg, 30-count bottle (NDC 0591-2167-30), 90-count bottle (NDC 0591-2167-19), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054

D-0986-2018

July 16, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 80538
Status
Ongoing
Classification
Class II
Quantity
8,046 30-count bottles, 20,841 90-count bottles
Official record key
drug-enforcement:D-0986-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot Numbers: NDC 0591-2167-30 1196936A, 1238463A, 1270617A NDC 0591-2167-19 1196934M, 1238462M, 1268429A

Distribution pattern: Product was distributed throughout the United States, including Hawaii and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations